Lexicon Pharmaceuticals (LXRX) EBT Margin Growth (5y) (2015 - 2025)
Lexicon Pharmaceuticals (LXRX) EBT Margin Growth (5y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lexicon Pharmaceuticals | 979.13 Mn | 808.47 Mn | 20.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 245,526.00 |
| Jun 30, 2025 | 28.10 Mn |
| Mar 31, 2025 | -143,495.00 |
| Dec 31, 2024 | 44,090.00 |
| Sep 30, 2024 | -397,726.00 |
| Jun 30, 2024 | -74,445.00 |
| Mar 31, 2024 | -367,608.00 |
| Dec 31, 2023 | -671,083.00 |
| Sep 30, 2023 | -3.66 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Jun 30, 2022 | -7.44 Mn |
| Dec 31, 2020 | -282,955.00 |
| Jun 30, 2020 | -27.35 Mn |
| Mar 31, 2020 | 73,546.00 |
| Dec 31, 2019 | -56,545.00 |
| Sep 30, 2019 | 981,158.00 |
| Jun 30, 2019 | 117,992.00 |
| Mar 31, 2019 | 1.02 Mn |
| Dec 31, 2018 | 104,254.00 |
| Sep 30, 2018 | 1.29 Mn |